NCT04600518View on ClinicalTrials.gov

Single Patient Classifier (SPC) Prediction for Stage II and III Advanced Gastric Cancer

CompletedOBSERVATIONAL
Enrollment

2,047

Participants

Timeline

Start Date

October 7, 2020

Primary Completion Date

June 18, 2023

Study Completion Date

June 22, 2023

Conditions
Gastric Cancer
Interventions
DEVICE

nProfiler I Stomach Cancer Assay Kit

nProfiler I Stomach Cancer Assay Kit (Novomics Co., Korea)

Trial Locations (1)

07217

Novomics. Co., Ltd., Seoul

All Listed Sponsors
lead

Novomics. Co., Ltd.

INDUSTRY

NCT04600518 - Single Patient Classifier (SPC) Prediction for Stage II and III Advanced Gastric Cancer | Biotech Hunter | Biotech Hunter